U.S. health advisers are debating a new kind of flu vaccine. The new shot is made with the same mRNA technology that was key to ending the COVID-19 pandemic. Moderna is seeking Food and Drug Administration approval for mFlusiva as an option for people 50 and …
U.S. health advisers are currently debating a pioneering flu vaccine developed by Moderna. This new shot utilizes the advanced mRNA technology, similar to that used in COVID-19 vaccines. Moderna is seeking FDA approval for its mFlusiva vaccine, specifically targeted for…
Market Samachar is a news aggregator. This article was originally published by Associated Press. Tap the button above to read the full story on their site.